RE-BVS – Piemonte Repository

Sfoglia per AUTORE
JAGANNATH S
Collezione AOU Città della Salute di Torino

Items : 6

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. in Nature genetics / Nat Genet. 2024 Sep;56(9):1878-1889. doi: 10.1038/s41588-024-01853-0. Epub 2024 Aug 19.

2024
AOU Città della Salute di Torino

Craig D; Rogers J; DeRome M; Toone M; McBride K; Zaugg B; Donnelly A; Kidd P; Stumph J; Collison K; Gamella M; D'Agostino M; Kirchhoff M; Rohrer DC; Livermore B; Blanski A; Tassone E; Stephenson K; Reiman R; McDonald J; Kyman S; Helland A; Boateng M; Cuyugan L; Adkins JR; Yellapantula V; Washington M; Kurdoglu A; Turner B; et alii...

Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2023 Jun;23(6):413-419. doi: 10.1016/j.clml.2023.03.009. Epub 2023 Mar 2

2023
AOU Città della Salute di Torino

Dhodapkar MV; Avigan DE; Ludwig H; Jagannath S; Parekh S; D'Agostino M; van de Donk NWCJ; Neri P; Terpos E; Raje NS;

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2019 Sep;6(9):e459-e469. doi: 10.1016/S2352-3026(19)30110-3. Epub 2019 Jul 18.

2019
AOU Città della Salute di Torino

Mateos MV; Blacklock H; Schjesvold F; Oriol A; Simpson D; George A; Goldschmidt H; Larocca A; Chanan-Khan A; Sherbenou D; Avivi I; Benyamini N; Iida S; Matsumoto M; Suzuki K; Ribrag V; Usmani SZ; Jagannath S; Ocio EM; Rodriguez-Otero P; San Miguel J; Kher U; Farooqui M; Liao J; Marinello P; Lonial S;

Advances in targeted therapy for the treatment of patients with relapsed/refractory multiple myeloma. in Expert review of hematology / Expert Rev Hematol. 2016 Jan;9(1):91-105. doi: 10.1586/17474086.2016.1119041.

2016
AOU Città della Salute di Torino

Le Ray E; Jagannath S; Palumbo A;

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.

2016
AOU Città della Salute di Torino

Kumar S; Paiva B; Anderson KC; Durie B; Landgren O; Moreau P; Munshi N; Lonial S; Bladé J; Mateos MV; Dimopoulos M; Kastritis E; Boccadoro M; Orlowski R; Goldschmidt H; Spencer A; Hou J; Chng WJ; Usmani SZ; Zamagni E; Shimizu K; Jagannath S; Johnsen HE; Terpos E; Reiman A; Kyle RA; Sonneveld P; Richardson PG; McCarthy P; et alii...

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.

2014
AOU Città della Salute di Torino

Rajkumar SV; Dimopoulos MA; Palumbo A; Blade J; Merlini G; Mateos MV; Kumar S; Hillengass J; Kastritis E; Richardson P; Landgren O; Paiva B; Dispenzieri A; Weiss B; LeLeu X; Zweegman S; Lonial S; Rosinol L; Zamagni E; Jagannath S; Sezer O; Kristinsson SY; Caers J; Usmani SZ; Lahuerta JJ; Johnsen HE; Beksac M; Cavo M; Goldschmidt H; et alii...